Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 12 minutes agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Drug shortages: What to do when you can’t get your medicine
Deseret News via Yahoo News· 17 hours ago“These are drugs we’ve used forever.” But what causes shortages? And more to the point, what do you...
Janus Henderson's Pinto Sees Big Pharma in `Golden Era'
Bloomberg· 38 minutes agoPharmaceutical companies are enjoying a ``golden era'' of innovation, with new drugs such as GLP-1s...
... To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To...
Benzinga· 2 hours agoPharmaceutical companies have been at the forefront of artificial intelligence for quite some time....
“Making The Shift”: 6 things we learned from Oprah Winfrey's live broadcast with WeightWatchers
Salon via Yahoo News· 25 minutes agoBack in March, the entertainment mogul announced that she will be leaving the board of...
Cancer Drug Price-Cutting Pitch Mulled by HHS as Industry Waits
Bloomberg Law· 11 hours agoThe Biden administration is weighing a drug pricing control proposition that attorneys and industry watchers say could bolster efforts to lower prescription costs even if ...
Here’s how many American adults have taken Ozempic or a similar drug for weight loss
TheGrio via Yahoo News· 7 hours agoThroughout the past year, pharmaceutical companies have scrambled to meet the increasing demand and...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 2 days agoEli Lilly is also racing to increase supply, with seven manufacturing sites either ramping up or...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Boston Herald· 2 hours agoWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Reuters via AOL· 2 hours agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...